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TRAF6 (TNF receptor-associated factor 6) or impair-
ment of ubiquitin binding are scarce. Rather common 
mutations of NEMO (NF-κB essential modulator) are de-
scribed in patients with hypohidrotic ectodermal dyspla-
sia accompanied by immunodeficiency and incontinentia 
pigmenti  [3] . Recent investigations showed increasingly 
that ectodermal dysplasias result from related defective 
molecular pathways. The aim of a new planed nosology 
and classification is to give pediatricians, dermatologists, 
geneticists, ophthalmologists and otorhinolaryngologists 
a table of genetic disorders involving the ectoderm which 
can help with the diagnosis, estimation of prognosis, 
work-up and therapy in individual patients, the delinea-
tion of new diseases and the building of bridges between 
clinicians and scientists  [4] .
 As more than 200 different ectodermal dysplasias ex-
ist, there is a remarkable overlapping of syndromic phe-
notypes. By 2008, 62 clinically different ectodermal dys-
plasias had already had a gene or a chromosome region 
assigned to them, and this number continues to rise  [5] . 
Unfortunately, besides the syndrome-associated find-
ings, patients often have other solitary nonsyndromic
abnormalities, so that straightforward diagnosis can be 
difficult. In addition, de novo genetic mutations will
continuously produce new ectodermal diseases  [6] . New 
technologies such as genome-wide association studies 
and array-comparative genomic hybridization as well as 
whole-exome and genome sequencing have started the 
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 Genetic diseases involving ectodermal systems result 
from a disturbance in the complex development of the 
skin and its appendages as well as other ectodermal struc-
tures. Ectodermal dysplasias describe a large and complex 
group of disorders characterized by abnormal formation 
of the skin, its appendages (hair, nails, teeth, sweat glands 
and sebaceous glands) and other organs which develop 
from ectoderm such as the nervous system, tooth enamel, 
the lens of the eye and the mammary glands. They involve 
various organs developing from the primordial external 
germ layer. They may occur in isolation or in association 
with other more complex clinical manifestations involv-
ing the mesoderm and endoderm. Most syndromic forms 
of ectodermal dysplasias are recognized by particular 
clinical features  [1] . In this issue, Yin et al.  [2]  described 
a deletion mutation in exon 8 of the EDA (ectodysplasin-
A) gene as a cause for X-linked hyphidrotic ectodermal 
dysplasia. Hypohidrotic ectodermal dysplasia can devel-
op from different mutations belonging to the TNF-α-like 
signaling pathway. Numerous mutations in the EDA gene 
have been reported, but EDA1R (ectodysplasin-1 recep-
tor) or EDARADD (ectodysplasin-A receptor-associated 
adapter protein) defects are rarer and mutations in 
 Published online: April 26, 2013 
 Peter H. Itin 
 Department of Dermatology,  University Hospital Basel 
 Petersgraben 4
CH–4031 Basel (Switzerland) 
 E-Mail peter.itin @ unibas.ch 



























   
   
   
   


























‘omics revolution’ and will lead to the detection of many 
new Mendelian disorders and their causative genes  [7] . 
The ‘interactome’ distinguishes essential genes which 
lead to intrauterine abortion if missing, and nonessential 
genes which may lead to syndromal diseases. The new 
knowledge concerning biological networks in medicine 
has shown that even the phenotype in monogenic disor-
der is rarely a consequence of an abnormality in a single 
effector gene product, but reflects various pathobiological 
processes that interact in a complex network  [8] . Disease 
pathways can be constructed according to topologically 
close genes or their products, functionally similar genes 
or their products and disease genes or their products  [8] .
 Modern identification of disease gene candidates uses 
linkage methods, disease-module-based methods with 
clustering or graph-partitioning and diffusion-based 
methods. Recently, next-generation sequencing as a diag-
nostic tool in groups of syndromic diseases has used pan-
els of several hundred genes which have been composed 
to identify disease-causing mutations in patients with 
syndromic epilepsy  [9] . This has the advantage that the 
amount of data is restricted. A gene panel seems to be a 
fast and cost-efficient method to analyze the genetic basis, 
and could also be of help in ectodermal dysplasia. Indeed, 
only 10% of human genes have a known disease associa-
tion.
 In 1798, Willan proposed a method for the diagnosis 
of skin diseases and a nosology for cutaneous disorders 
 [10] . In 1829, Alibert suggested a new concept of skin dis-
eases by dividing them into twelve branches which he 
named the tree of dermatoses  [11] . For him, the natural 
connections between the cutaneous efflorescences in the 
different skin diseases were important. In 1900, Brocq in-
troduced the idea of the phenomenon of transfer between 
skin diseases, which meant that they are all somehow 
linked  [11] . Classification of disease is an ongoing process 
that is influenced by clinical aspects, diagnostic skills and 
modalities, medical intervention, molecular understand-
ing and community consensus  [7] . Defining recognizable 
patterns of features and highlighting those that allow one 
condition to be distinguished from another (key features) 
includes the process of modern classification  [12] . Unfor-
tunately, such an approach has important shortcomings 
including a lack of sensitivity in identifying preclinical 
disease. Itin and Fistarol  [1]  also emphasized that, rather 
commonly, oligosymptomatic phenotypes exist in the 
spectrum of ectodermal dysplasias, which makes a clini-
cal diagnosis more difficult. With the impressive molecu-
lar genetic progress and the increase of electronic data-
bases, a new principal approach of classifying diseases has 
begun  [13] . The combination of clinical key features 
( fig. 1 a–d) and key molecular-signaling pathways will de-
fine the new classification scheme of ectodermal dyspla-
sia. With the introduction of electronic health records, 
new potential arises for understanding genotype-pheno-
type relationships and for establishing new networks for 
unknown diseases. Modern possibilities evolve with the 
data-mining that occurs in such data sources combined 
with molecular genetic information  [14] .
a b c
d e
 Fig. 1.  a Typical malformed teeth in anhidrotic 
ectodermal dysplasia.  b Almost absent eyebrows 
and cilia in different ectodermal dysplasias.  c Ru-
dimentary or absent finger ridges in several ecto-
dermal syndromes.  d Ectrodactylia in p63 muta-
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 All diseases are a result of the interaction between ge-
netic constellations and environmental influences. Ge-
nome-transcriptome-proteome constellations and envi-
ronmental perturbations lead to intermediate pathophe-
notypes and clinical syndromes and diseases  [15] . This is 
why an understanding of the network context of a gene is 
essential in determining the phenotypic impact of the 
mutations and functional consequences that affect the 
phenotype  [8] . Diseases originate from pathologies in or-
gans comprised of different cells and biological structures 
with intracellular and intercellular molecular interac-
tions. The human genome has about 30,000 genes. In 
2007, 2,418 of these genes were associated with specific 
diseases. There made for an overlap of 1,777 disease-as-
sociated genes that were already known. The disease em-
bryo development network reveals the relationship be-
tween disease genes and embryo development genes. An 
approach based on this network could document the im-
portant correlation between disease processes and em-
bryo development, and aid in the understanding of the 
potential mechanisms of complex human diseases  [16] . 
The term ‘human interactome’ has been created to de-
scribe this network medicine. However, there is a long 
way to go before a reliable network-based approach to 
disease is attained, because of the incompleteness of the 
available interactome maps at present and the limitations 
of the existing tools for exploring the pathogenetic rela-
tionships of diseases  [8] .
 In my personal opinion, nowadays, the term ectoder-
mal dysplasia is too broad and is not clearly reproducible. 
Most genetic skin disorders are somehow linked to the 
ectoderm, according to the development fields by Spe-
mann, because the skin develops from ectoderm and me-
soderm. Recognizing the complex network with the over-
lapping functions of the key genes that are responsible for 
the development of ectoderm, the term ectodermal dys-
plasia shifts more to the generalized term genodermato-
sis. This tendency is not helpful for general practice and 
should be corrected. A group of experts has compiled an 
extensive list (to which I have also contributed) of ecto-
dermal diseases for the new ICD-11 classification, with 
the aim of providing clinicians with a list of those diseas-
es which belong to ectodermal dysplasia. However, this 
list is incomplete and is not very systematic. Should cuta-
neous disorders with primary vascular malformations, 
dermal abnormalities or immunological disturbances be 
excluded? What about skin and bone diseases? In all these 
disease groups, there is much overlapping with clear ec-
todermal dysplasia such as mutation in the NEMO gene 
with immunodeficiency. Classification of ectodermal 
dysplasia needs a consensus which will be consolidated 
within the next 12 months by a panel of experts. To define 
ectodermal dysplasia, clear, clinical features of a syn-
drome should be included, but molecular genetic aspects 
also have to be taken into account. For classifying ecto-
dermal dysplasia, I suggest that the skin or its append-
ages should be the major clinical features presented
( table 1 ). This is important, as several genes can have dif-
ferent mutations which can lead to totally variable
phenotypes, some with primary skin problems and some 
with primary noncutaneous lesions  [17] . As an addition-
al criterium, the molecular defect should include one of 
the most important pathways for ectodermal develop-
ments or ectodermal key genes such as ectodysplasin, 
p63, WNT and their pathways. As ectodermal dysplasias 
can have life-long consequences, genetic analysis should 
be recommended for anticipating the prognostic factors 
of the disease, and could therefore be implicated in the 
classification recommendations. We are aware that not 
all countries have the costs of mutation analysis covered 
by insurance companies. In the near future, targeted se-
quence capture and high-throughput sequencing in the 
molecular diagnosis of a defined group of ectodermal 
dysplasias will become possible and this should be more 
affordable  [18] . 
 
Table 1.  Criteria for ectodermal dysplasia entities
– The major clinical signs and symptoms affect the skin and/or 
its appendages
– They are persistent and not progressive
– The molecular mutation involves ectodermal key signaling 
pathways such as p63, ectodysplasin and WNT
– Molecular mutations lead to functional or structural changes 
in the ectoderm
– Regulators and coregulators of ectodermal genes are involved 
and are changed
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